Proteomics International Webinar and Q&A on PromarkerD Reimbursement

Proteomics International Laboratories Ltd (Proteomics International; the Company; ASX: PIQ) is pleased to invite shareholders, investors and interested parties to an online update on the recent announcement regarding the PromarkerD US Reimbursement Price and the Australian Regulatory Decision, hosted by MD, Dr Richard Lipscombe.

The webinar will be held on Tuesday 3rd October 2023 at 12:00pm AEDT / 11:00am AEST / 9:00am AWST

Register for the webinar

After registering, you will receive a confirmation email containing information about joining the webinar. A
recording will be available at the above link shortly after the conclusion of the live session.

For the Q&A session, investors are invited to send questions for the webinar prior to 5:00pm AEDT Monday 2nd October 2023 to: